- Home
- SER vs PRTS Comparison
SER vs PRTS Comparison
Compare SER & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SER | PRTS |
|---|---|---|
| Founded | 2017 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 54.7M |
| IPO Year | 2024 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SER | PRTS |
|---|---|---|
| Price | $1.70 | $7.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $9.50 | ★ $10.85 |
| AVG Volume (30 Days) | ★ 28.7K | 26.7K |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $130,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.14 | N/A |
| 52 Week Low | $1.22 | $0.37 |
| 52 Week High | $5.29 | $10.98 |
Technical Indicators
Market Signals| Indicator | SER | PRTS |
|---|---|---|
| Relative Strength Index (RSI) | 35.23 | 44.15 |
| Support Level | $1.73 | $5.91 |
| Resistance Level | $1.86 | $8.82 |
| Average True Range (ATR) | 0.11 | 0.31 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 15.38 | 25.48 |
Price Performance
Historical ComparisonAbout SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. Its products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.